Looking to lead a stronger, healthier life?
Sign up for our Wellness Wire newsletter for all sorts of nutrition, fitness, and wellness wisdom.

Now we’re in this together.
Thanks for subscribing and having us along on your health and wellness journey.

See all Healthline's newsletters »
It's a Type 2 Life
It's a Type 2 Life

San Francisco Bay Area resident Patrick Totty writes about his experiences living with type 2 diabetes

See all posts »

A Rival to Swiss Chocolate?

Although many people think that type 1 diabetics are the only people who take insulin injections, an estimated 11 million type 2s in Europe and North America are also on insulin therapy.

They deal with many of the same hassles that type 1s do, including having to take multiple daily injections.

No matter how practiced they are, there are still numerous demands imposed by their routine: remembering when to take insulin; checking to see that the insulin is not outdated or has been heat damaged; and making sure the dose is correct.  

There’s also the problem of bad timing or concerns about public exposure. No matter how fluid their movements or how discreet they are, there are just some locations and occasions when injecting insulin isn’t a good idea.

What would be welcome is a simple injection device for type 2s, hidden under clothes, that would quietly deliver insulin at set times.

Well, such a device may be in the offing. A Swiss company, CeQur SA, has completed a clinical study of its PaQ® insulin delivery device and expects to share the test results early next year.

The device, which provides three days of basal insulin delivery, plus on-demand bolus insulin*, consists of a disposable insulin infuser reservoir that’s attached to a reusable insulin monitor.

Researchers at University Hospital Graz in Austria divided the study into three two-week segments: baseline, which established patients’ dosing needs and habits; transition to the PaQ device; and then daily use of the device and the results from it.

If PaQ proves to be a reliable insulin delivery system, it could go a long way toward increasing the number of compliant insulin-using type 2s. Some medical experts estimate that half of all patients who require multiple daily insulin injections deliberately skip doses if injecting themselves disrupts their routines or embarrasses them.

For more information on CeQur and the PaQ system, link here.

*Basal insulin is long-lasting insulin that works over a 24-hour period. Bolus insulin is shorter-lasting, quick-acting insulin that works to counter the high blood sugar spikes that often occur after a person with diabetes has eaten. 



  • 1

Tags: Food

Was this article helpful? Yes No

About the Author

Bay Area resident Patrick Totty was diagnosed with type 2 diabetes in July, 2003.